Re: TD Zenith Capital Corp | Grey Market : ZHCLF
in response to
by
posted on
Oct 16, 2020 04:24PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
"And it appears they looked into it because they disconnected it from ZHCLF a couple months ago"
well kinda - what TD did a couple months ago is get the price back to $2US which is correct but they didn't do is disconnect the ZHLCF attached to that $2US so that's messed up & then like I posted earlier today the TD downgraded the value to $1US overnight & the ZHLCF tag still sits beside itÂ